Acodis Secures CHF 6M in Series A Funding for Pharma and Health Expansion
Swiss intelligent document processing (IDP) platform Acodis has secured CHF 6 million in a Series A funding round. The company, led by CEO Martin Keller, has seen significant growth and market recognition in the past year.
The funding round was led by Hi Inov and VI Partners. The funds will be used to expand Acodis' position in the pharma and health sectors, where it has already made a strong impact. Despite no public information on specific adopters, Acodis has won and onboarded 3 of the 10 largest pharma companies for automated document processing at scale in the past year.
Acodis' SaaS solution is trusted by these industry giants for document processing automation and data analytics. The company launched a no-code platform for advanced document analysis and document structure extraction, further enhancing its offerings. This success has earned Acodis multiple awards in the past year.
Acodis' Series A funding round, led by Hi Inov and VI Partners, totals CHF 6 million. The funds will drive expansion in the pharma and health sectors, where Acodis has already proven its value. The company's CEO, Martin Keller, sees this financing as a testament to Acodis' market relevance and potential.
Read also:
- Germany Launches HoLa Project for Megawatt Charging on A2 Motorway
- Wallenius Wilhelmsen Leads Maritime Industry's Push to Net Zero Emissions by 2027
- Transforming Digital Inventories in the Food Industry: A Comprehensive Guide for Food Businesses
- Munich Airport Unveils Its New Electrical Vehicle Charging Parksite
